Safety and Pharmacokinetics of Recombinant Factor XIII in Healthy Volunteers

Clinical trial NCT01847989 · COMPLETED

Trial details

NCT number: NCT01847989
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Congenital Bleeding Disorder Congenital FXIII Deficiency Healthy

Start date: 2003-01-01
Primary completion: 2003-05-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.